Prognostic parameters of endometrial carcinoma.

作者: Jaime Prat

DOI: 10.1016/J.HUMPATH.2004.02.007

关键词: OncologyCarcinomaNuclear atypiaSerous fluidHysterectomyAdenocarcinomaPathologyInternal medicineStage (cooking)Clear cellAnatomical pathologyMedicine

摘要: Endometrial carcinoma is the most common malignant tumor of female genital tract in Western world. Approximately 80% cases are well- to moderately differentiated (endometrioid) adenocarcinomas, which confined uterine corpus at diagnosis, and thus can be cured. Conversely, high-grade (ie, clear cell serous) carcinomas account for only 15% 20% show marked nuclear atypia. These tumors usually invade myometrium may extend beyond uterus time hysterectomy. In addition clinical morphological differences, these 2 groups endometrial differ their pathogenesis. Whereas prognosis latter group generally poor, pathologist's role establishing outcome former crucial. Furthermore, it has become progressively apparent that both overlap some extent, making dualistic model a guideline best. Over last decades, several studies have demonstrated prognostic importance various key surgical pathological parameters, including histological type, grade, surgical-pathological stage, depth myometrial invasion, vascular cervical involvement. This review presents important factors from viewpoint, attempts clarify existing conflicts classification diagnosis tumors.

参考文章(119)
Michael Hendrickson, Jon Ross, Patricia J. Eifel, Richard S. Cox, Alvaro Martinez, Richard Kempson, Adenocarcinoma of the endometrium: Analysis of 256 cases with carcinoma limited to the uterine corpus: Pathology review and analysis of prognostic variables☆☆☆ Gynecologic Oncology. ,vol. 13, pp. 373- 392 ,(1982) , 10.1016/0090-8258(82)90076-2
P J Disaia, R C Boronow, J A Blessing, A Miller, C P Morrow, W T Creasman, S G Silverberg, Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstetrics & Gynecology. ,vol. 63, pp. 825- 832 ,(1984)
Silva Eg, Jenkins R, Serous carcinoma in endometrial polyps. Modern Pathology. ,vol. 3, pp. 120- ,(1990)
David M. Gershenson, Neely Atkinson, Nour Sneige, Deborah A. Turner, A. Taylor Wharton, The prognostic significance of peritoneal cytology for stage I endometrial cancer Obstetrics & Gynecology. ,vol. 74, pp. 775- 780 ,(1989)
K R Cho, T D Kessis, L Hedrick, R T Burks, Microsatellite instability in endometrial carcinoma. Oncogene. ,vol. 9, pp. 1163- 1166 ,(1994)
Joseph T. Chambers, Maria Luisa Carcangiu, Irene M. Voynick, Peter E. Schwartz, Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: Correlation between biochemical and immunohistochemical methods and survival. American Journal of Clinical Pathology. ,vol. 94, pp. 255- 260 ,(1990) , 10.1093/AJCP/94.3.255
Kurman Rj, Lax Sf, A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Pathology Research and Practice. ,vol. 81, pp. 228- 232 ,(1997)
Marian S. Blazes, Kathleen R. Cho, Steven I. Wang, Ramon Parsons, Shikha Bose, Lora Hedrick Ellenson, Hironori Tashiro, Jing Li, Rong Wu, Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Research. ,vol. 57, pp. 3935- 3940 ,(1997)
Robert J. Kurman, Christina Isacson, Kathleen R. Cho, Ross Levine, Hironori Tashiro, Lora Hedrick, p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis American Journal of Pathology. ,vol. 150, pp. 177- 185 ,(1997)
Andrew Berchuck, John I. Risinger, J. Carl Barrett, A. Kate Hayes, PTEN/MMAC1 Mutations in Endometrial Cancers Cancer Research. ,vol. 57, pp. 4736- 4738 ,(1997)